Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-31,500
Closed -$290K 13258
2025
Q4
$290K Buy
+31,500
New +$273K ﹤0.01% 10224
2025
Q2
Sell
-200
Closed -$1.76K 13141
2025
Q1
$1.76K Sell
200
-1,300
-87% -$10.9K ﹤0.01% 14098
2024
Q4
$11.7K Sell
1,500
-7,000
-82% -$53.2K ﹤0.01% 13536
2024
Q3
$67.2K Sell
8,500
-55,400
-87% -$482K ﹤0.01% 11608
2024
Q2
$570K Sell
63,900
-25,800
-29% -$247K ﹤0.01% 7794
2024
Q1
$1.05M Buy
+89,700
New +$899K ﹤0.01% 6822
2023
Q4
Sell
-16,200
Closed -$182K 14484
2023
Q3
$182K Buy
16,200
+10,700
+195% +$135K ﹤0.01% 10065
2023
Q2
$63.3K Buy
5,500
+3,800
+224% +$47.4K ﹤0.01% 11529
2023
Q1
$23.6K Sell
1,700
-6,150
-78% -$88.4K ﹤0.01% 12929
2022
Q4
$103K Buy
+7,850
New +$105K ﹤0.01% 11171

Other funds holding EHAB

Citadel Advisors's EHAB Position: Q1 2026 in Review

Citadel Advisors reduced its Enhabit (EHAB) stake by 53% in Q1 2026, selling an estimated $2.65M and leaving 196,897 shares worth $2.77M. The position accounts for ﹤0.01% of the portfolio, ranked #5422.

Citadel Advisors first reported a position in EHAB in Q3 2022 and has held it in 14 quarters since. The position peaked at $6.79M in Q3 2024. 174 funds tracked by Wall St. Rank hold EHAB as of Q1 2026.

  • Citadel Advisors held 196,897 shares of Enhabit worth $2.77M as of Q1 2026.
  • Citadel Advisors sold 221,221 Enhabit shares in Q1 2026, an estimated $2.65M.
  • Enhabit made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5422 holding.
  • Citadel Advisors first reported a position in Enhabit in Q3 2022 and has held it in 14 quarters since.
  • Citadel Advisors's Enhabit position peaked at $6.79M in Q3 2024.
  • 174 funds tracked by Wall St. Rank held Enhabit as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.